We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

87 hedge funds and large institutions have $39M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

213% more call options, than puts

Call options by funds: $1.78M | Put options by funds: $570K

148% more capital invested

Capital invested by funds: $15.8M → $39M (+$23.2M)

21% more funds holding

Funds holding: 72 → 87 (+15)

14% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 28

Holders
87
Holders Change
+15
Holders Change %
+20.83%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
24
Reduced
28
Closed
7
Calls
$1.78M
Puts
$570K
Net Calls
+$1.21M
Net Calls Change
+$710K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.97M
2
Group One Trading
Group One Trading
Illinois
+$892K
3
Aberdeen Group
Aberdeen Group
United Kingdom
+$796K
4
SSA
Schonfeld Strategic Advisors
New York
+$640K
5
Morgan Stanley
Morgan Stanley
New York
+$573K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.91M
2
BlackRock
BlackRock
New York
-$826K
3
RJA
Raymond James & Associates
Florida
-$677K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$489K
5
Marshall Wace
Marshall Wace
United Kingdom
-$294K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$383K +$49.2K +26,180 +26%
DA
27
Denali Advisors
California
$371K -$50.7K -27,000 -18%
BCM
28
Bridgeway Capital Management
Texas
$366K -$37.6K -20,000 -14%
FCA
29
FinTrust Capital Advisors
South Carolina
$307K +$189K +100,715 +154,946%
Citigroup
30
Citigroup
New York
$262K +$160K +85,306 +13,267%
FSA
31
Franklin Street Advisors
North Carolina
$254K – – –
BC
32
Birchview Capital
Vermont
$244K -$75.2K -40,000 -33%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$234K +$4.24K +2,258 +3%
CWM
34
Curi Wealth Management
North Carolina
$216K +$100 +53 +0.1%
6CM
35
683 Capital Management
New York
$194K +$120K +63,765 New
Fidelity Investments
36
Fidelity Investments
Massachusetts
$187K +$96.2K +51,182 +505%
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$177K -$138K -73,230 -56%
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
$144K +$88.9K +47,296 New
EGM
39
Engineers Gate Manager
New York
$136K +$56.9K +30,281 +211%
VF
40
Virtu Financial
New York
$136K +$84K +44,726 New
Citadel Advisors
41
Citadel Advisors
Florida
$134K -$182K -96,852 -69%
BPA
42
Beacon Pointe Advisors
California
$133K +$1.31K +700 +2%
AG
43
Algert Global
California
$117K -$55.7K -29,630 -44%
Ameriprise
44
Ameriprise
Minnesota
$108K -$4.79K -2,550 -7%
CFD
45
Creative Financial Designs
Indiana
$108K +$32.8K +17,475 +98%
CL
46
Choreo LLC
Illinois
$107K +$66.2K +35,234 New
JF
47
Jump Financial
Illinois
$105K +$64.6K +34,400 New
RJFSA
48
Raymond James Financial Services Advisors
Florida
$103K -$18.3K -9,727 -22%
Millennium Management
49
Millennium Management
New York
$94.7K -$1.91M -1,017,949 -97%
Envestnet Asset Management
50
Envestnet Asset Management
Illinois
$84.4K +$6.13K +3,262 +13%
1
2
3 4

GTHX Hedge Fund Activity: Q4 2023 in Review

87 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q4 2023, worth a combined $39M — up 148% from $15.8M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new GTHX positions and 7 closed out — a net gain of 15 holders — while 24 added to existing stakes and 28 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.97M. The largest seller was Millennium Management, cutting an estimated $1.91M.

  • 87 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q4 2023, up from 72 in Q3 2023.
  • Funds reported $39M of G1 Therapeutics, Inc. Common Stock stock for Q4 2023, up 148% quarter-over-quarter.
  • 22 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q4 2023 and 7 closed out, a net change of +15 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q4 2023 was Susquehanna International Group, an estimated $2.97M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q4 2023 was Millennium Management, an estimated $1.91M sold.

Based on aggregated 13F filings for Q4 2023.